FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

703891000168103: Temozolomide (Apo) (temozolomide 20 mg) capsule, 5 capsules, bottle (containered trade product pack)


Status: current, Defined. Date: 30-Jun 2015. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2439911000168116 Temozolomide (Apo) (temozolomide 20 mg) capsule, 5 capsules, bottle (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2439921000168111 Temozolomide (Apo) 20 mg capsule, 5, bottle en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Temozolomide (Apo) (temozolomide 20 mg) capsule, 5 capsules, bottle (containered trade product pack) has TP Temozolomide (Apo) true Inferred relationship Some
Temozolomide (Apo) (temozolomide 20 mg) capsule, 5 capsules, bottle (containered trade product pack) has TPUU Temozolomide (Apo) 20 mg capsule true Inferred relationship Some 1
Temozolomide (Apo) (temozolomide 20 mg) capsule, 5 capsules, bottle (containered trade product pack) Is a containered trade product pack true Inferred relationship Some
Temozolomide (Apo) (temozolomide 20 mg) capsule, 5 capsules, bottle (containered trade product pack) Is a Temozolomide (Apo) 20 mg capsule, 5 true Inferred relationship Some
Temozolomide (Apo) (temozolomide 20 mg) capsule, 5 capsules, bottle (containered trade product pack) has container type bottle true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start